Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data REZOLVE AI PLC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2024
FY2025
Revenue
0.15
2.01
46.8
Research and development
1.15
11.2
Selling and marketing
6.73
6.68
12.1
General and administrative
18
132
90.4
Operating expenses
26.2
141
134
Operating income
-26
-139
-86.9
Interest expense
4.79
10.6
2.91
Other non-operating income
0.13
1.29
0.47
Pre-tax income
-30.7
-173
-119
Income tax
0.06
0.24
-17.7
Net income
-30.7
-173
-101
EBITDA
-26
-138
-86.6
EPS, basic
-0.20
-1.06
-0.38
EPS, diluted
-0.20
-1.06
-0.38
Shares, basic (weighted)
151
164
268
Shares, diluted (weighted)
151
164
268
Balance sheet
FY2024
FY2024
FY2025
Cash and equivalents
9.4
9.73
111
Receivables
0.01
0.7
39.2
Other current assets
0.3
0.03
10.4
Total current assets
0.32
14
175
Property, plant and equipment
0.08
0.02
0.51
Lease right-of-use assets
2.99
Goodwill
168
Intangible assets
2.13
6.75
239
Other non-current assets
0.37
3.7
Total assets
2.54
21.2
612
Accounts payable
4.57
8.06
35.7
Accrued liabilities
4.49
9.51
20.4
Deferred revenue
1.17
46.5
Short-term debt
47
37.3
102
Total current liabilities
56.8
62.4
262
Long-term debt
50.1
Lease liabilities
0.83
Other non-current liabilities
0.4
Total liabilities
56.8
62.4
365
Total debt
50.1
Paid-in capital
172
217
606
Retained earnings
-226
-258
-360
Other comprehensive income
-0.15
0.03
0.81
Shareholders' equity
-58.2
-41.3
247
Total equity
-58.2
-41.3
247
Total liabilities and equity
2.54
21.2
612
Cash flow statement
FY2024
FY2024
FY2025
Net income
-30.7
-173
-101
Depreciation and amortization
0.04
0.04
0.27
Stock-based compensation
3.27
63
6.4
Deferred income tax
0
-18.5
Change in receivables
-0
-0.63
-18.5
Cash from operations
-13
-22.4
-63.1
Capital expenditures
-0.01
-0.01
-0.09
Purchases of investments
-5.46
Cash from investing
-1.78
-3.53
-24.7
Debt issued
2.63
27
Debt repaid
-33.5
Stock issued
18.3
251
Cash from financing
14.7
35.4
189
Exchange rate effect
0.04
0.04
0.42
Net change in cash
-0.03
9.57
101
Free cash flow
-13
-22.4
-63.2
Interest paid
0.11
3
Income taxes paid
0
0.11
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.18 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-185.6%
Operating income / revenue.
EBITDA margin
-185.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-254.6%
Pre-tax income / revenue.
Net margin
-216.7%
Net income / revenue.
FCF margin
-135.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-134.9%
Cash from operations / revenue.
Return on equity (ROE)
-98.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-32.0%
Net income / average total assets.
Return on invested capital (ROIC)
-101.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
23.9%
Research and development expense / revenue.
Stock-based pay / revenue
13.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.2%
Capital expenditures / revenue.
D&A / revenue
0.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
2,224.0%
Revenue vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
2,790.0%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
63.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.67x
Current assets / current liabilities.
Quick ratio
0.57x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.42x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.20x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
8.2%
Total debt / total assets.
Liabilities / assets
59.7%
Total liabilities / total assets.
Net debt
-$61.0M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.38
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.17
Revenue / diluted weighted shares.
FCF per share
-$0.24
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.24
Cash from operations / diluted weighted shares.
Book value per share
$0.92
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
18.7x
Market cap / revenue.
P/B
3.54x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
17.3x
Enterprise value / revenue.
FCF yield
-7.2%
Free cash flow / market cap.
Earnings yield
-11.6%
Net income / market cap (the inverse of P/E).
What was REZOLVE AI PLC's revenue in fiscal 2025?
REZOLVE AI PLC reported revenue of $46.8M for fiscal 2025, 2,224.2% higher than the year before.
Was REZOLVE AI PLC profitable in fiscal 2025?
No. It reported a net loss of $101.4M.
How much free cash flow did REZOLVE AI PLC generate in fiscal 2025?
Cash from operations of $63.1M minus capital expenditures of $90.2K left free cash flow of -$63.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.